Warning! GuruFocus detected
1 Medium warning sign
with NERV.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Minerva Neurosciences Inc
NAICS : 325412
SIC : 2834
ISIN : US6033801068
Description
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -0.69 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year FCF Growth Rate | 17.6 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 16.28 | |||||
| 9-Day RSI | 25.48 | |||||
| 14-Day RSI | 30.93 | |||||
| 3-1 Month Momentum % | -30.7 | |||||
| 6-1 Month Momentum % | -39.76 | |||||
| 12-1 Month Momentum % | -37.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.85 | |||||
| Quick Ratio | 7.85 | |||||
| Cash Ratio | 7.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.4 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | Neg. Equity | |||||
| ROA % | 3.08 | |||||
| ROIC % | -139.52 | |||||
| 3-Year ROIIC % | 6919.47 | |||||
| ROC (Joel Greenblatt) % | 73170.73 | |||||
| ROCE % | 13.89 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 7.21 | |||||
| PE Ratio without NRI | 17.34 | |||||
| Price-to-Owner-Earnings | 9.26 | |||||
| EV-to-EBIT | -1.96 | |||||
| EV-to-EBITDA | -1.96 | |||||
| EV-to-FCF | 0.6 | |||||
| Earnings Yield (Greenblatt) % | -51.02 | |||||
| FCF Yield % | -204.05 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NERV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Minerva Neurosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0.19 | ||
| Beta | -0.13 | ||
| 3-Year Sharpe Ratio | 0.44 | ||
| 3-Year Sortino Ratio | 1.23 | ||
| Volatility % | 43.38 | ||
| 14-Day RSI | 30.93 | ||
| 14-Day ATR ($) | 0.150976 | ||
| 20-Day SMA ($) | 1.666495 | ||
| 12-1 Month Momentum % | -37.55 | ||
| 52-Week Range ($) | 1.26 - 3.69 | ||
| Shares Outstanding (Mil) | 6.99 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Minerva Neurosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Minerva Neurosciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Minerva Neurosciences Inc Frequently Asked Questions
What is Minerva Neurosciences Inc(NERV)'s stock price today?
The current price of NERV is $1.37. The 52 week high of NERV is $3.69 and 52 week low is $1.26.
When is next earnings date of Minerva Neurosciences Inc(NERV)?
The next earnings date of Minerva Neurosciences Inc(NERV) is 2025-05-01 Est..
Does Minerva Neurosciences Inc(NERV) pay dividends? If so, how much?
Minerva Neurosciences Inc(NERV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers